Value driven solutions

REG-Misys PLC <MSY.L> Healthcare Investor and Analy

Released: 13/05/2008


com:20080513:RnsM3251U
                                                                                                                       .
RNS Number : 3251U  
  
Misys PLC  
  
13 May 2008  
  
13 May 2008  
  
MISYS plc  
  
Raleigh, North Carolina (13 May, 2008) - Misys plc (FTSE: MSY.L), the global 
applications software and services company, will be holding a Healthcare 
Investor and Analysts event, jointly with Allscripts (Nasdaq: MDRX) tomorrow.  
  
No new material information will be released.  
  
ENDS  
  
MEDIA ENQUIRIES     ANALYST / INVESTOR ENQUIRIES  
  
 
  Carl Gibson                        John Kiernan                     
  T: +44 (0) 20 7368 2344            T:  + 44 (0)20 7368 2336         
  T: +1 917 804 0910                 T:  + 1 914 821 2606             
  M: +44 (0) 782 523 6473            M: + 1 646 233 9954              
  Email: carl.gibson@misys.com       Email:  john.kiernan@misys.com   
                                                                      
  
  
About Misys plc  
  
Misys plc (FTSE: MSY.L), provides integrated, comprehensive solutions that 
deliver significant results to organisations in the financial services and 
healthcare industries. We maximise value for our customers by combining our deep 
knowledge of their business with our commitment to their success.  
  
In banking and treasury & capital markets, Misys is a market leader, with over 
1,200 customers, including all of the world's top 50 banks. In healthcare, Misys 
is a market leader, serving more than 110,000 physicians in 18,000 practice 
locations and 600 home care providers. Misys employs around 4,500 people who 
serve customers in more than 120 countries.  
  
We aspire to be the world's best application software and services company, 
delivering results for the most important industries in the world.  
  
Misys: Experience, Solutions, Results  
  
Contact us today, visit: www.misys.com  
  
This information is provided by RNS  
  
The company news service from the London Stock Exchange  
  
END  
  
MSCFGGMKZFDGRZM